709 related articles for article (PubMed ID: 23396168)
21. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
22. 4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity.
Lee YJ; Choi DY; Lee YK; Lee YM; Han SB; Kim YH; Kim KH; Nam SY; Lee BJ; Kang JK; Yun YW; Oh KW; Hong JT
J Alzheimers Dis; 2012; 29(3):677-90. PubMed ID: 22330831
[TBL] [Abstract][Full Text] [Related]
23. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage.
Piermartiri TC; Figueiredo CP; Rial D; Duarte FS; Bezerra SC; Mancini G; de Bem AF; Prediger RD; Tasca CI
Exp Neurol; 2010 Dec; 226(2):274-84. PubMed ID: 20816828
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
25. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
Meunier J; Villard V; Givalois L; Maurice T
Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
[TBL] [Abstract][Full Text] [Related]
26. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
27. Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus.
Zhang J; Zhen YF; Pu-Bu-Ci-Ren ; Song LG; Kong WN; Shao TM; Li X; Chai XQ
Behav Brain Res; 2013 May; 244():70-81. PubMed ID: 23396166
[TBL] [Abstract][Full Text] [Related]
28. S-Allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits.
Pérez-Severiano F; Salvatierra-Sánchez R; Rodríguez-Pérez M; Cuevas-Martínez EY; Guevara J; Limón D; Maldonado PD; Medina-Campos ON; Pedraza-Chaverrí J; Santamaría A
Eur J Pharmacol; 2004 Apr; 489(3):197-202. PubMed ID: 15087243
[TBL] [Abstract][Full Text] [Related]
29. Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1-42) rat model of Alzheimer's disease.
Cioanca O; Hritcu L; Mihasan M; Hancianu M
Physiol Behav; 2013 Aug; 120():193-202. PubMed ID: 23958472
[TBL] [Abstract][Full Text] [Related]
30. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
31. Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Zou L; Nagai T; Hiramatsu M; Ikejima T; Nabeshima T
Br J Pharmacol; 2009 Aug; 157(7):1270-7. PubMed ID: 19552690
[TBL] [Abstract][Full Text] [Related]
32. Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.
Bagheri M; Joghataei MT; Mohseni S; Roghani M
Neurobiol Learn Mem; 2011 Mar; 95(3):270-6. PubMed ID: 21144907
[TBL] [Abstract][Full Text] [Related]
33. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
34. Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats.
Liu XJ; Yuan L; Yang D; Han WN; Li QS; Yang W; Liu QS; Qi JS
Synapse; 2013 Sep; 67(9):626-36. PubMed ID: 23620224
[TBL] [Abstract][Full Text] [Related]
35. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
36. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
Trent NL; Menard JL
Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
[TBL] [Abstract][Full Text] [Related]
37. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
[TBL] [Abstract][Full Text] [Related]
38. The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse.
Jeong EJ; Lee HK; Lee KY; Jeon BJ; Kim DH; Park JH; Song JH; Huh J; Lee JH; Sung SH
J Ethnopharmacol; 2013 Mar; 146(1):347-54. PubMed ID: 23333311
[TBL] [Abstract][Full Text] [Related]
39. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.
Li J; Wang C; Zhang JH; Cai JM; Cao YP; Sun XJ
Brain Res; 2010 Apr; 1328():152-61. PubMed ID: 20171955
[TBL] [Abstract][Full Text] [Related]
40. The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice.
Kim DH; Kim S; Jeon SJ; Son KH; Lee S; Yoon BH; Cheong JH; Ko KH; Ryu JH
Neuropharmacology; 2008 Oct; 55(5):639-47. PubMed ID: 18620712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
